Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.

Li B, VanRoey M, Wang C, Chen TH, Korman A, Jooss K.

Clin Cancer Res. 2009 Mar 1;15(5):1623-34. doi: 10.1158/1078-0432.CCR-08-1825. Epub 2009 Feb 10.

2.

Myeloid-derived suppressor cells as regulators of the immune system.

Gabrilovich DI, Nagaraj S.

Nat Rev Immunol. 2009 Mar;9(3):162-74. doi: 10.1038/nri2506. Review.

3.

Urokinase-mediated recruitment of myeloid-derived suppressor cells and their suppressive mechanisms are blocked by MUC1/sec.

Ilkovitch D, Lopez DM.

Blood. 2009 May 7;113(19):4729-39. doi: 10.1182/blood-2008-08-176438. Epub 2009 Feb 4.

4.
5.

Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma.

Kusmartsev S, Su Z, Heiser A, Dannull J, Eruslanov E, Kübler H, Yancey D, Dahm P, Vieweg J.

Clin Cancer Res. 2008 Dec 15;14(24):8270-8. doi: 10.1158/1078-0432.CCR-08-0165.

6.

Subsets of myeloid-derived suppressor cells in tumor-bearing mice.

Youn JI, Nagaraj S, Collazo M, Gabrilovich DI.

J Immunol. 2008 Oct 15;181(8):5791-802.

7.

B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer.

Liu Y, Zeng B, Zhang Z, Zhang Y, Yang R.

Clin Immunol. 2008 Dec;129(3):471-81. doi: 10.1016/j.clim.2008.07.030. Epub 2008 Sep 14.

PMID:
18790673
8.

Imagable 4T1 model for the study of late stage breast cancer.

Tao K, Fang M, Alroy J, Sahagian GG.

BMC Cancer. 2008 Aug 9;8:228. doi: 10.1186/1471-2407-8-228.

9.

Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.

Haile LA, von Wasielewski R, Gamrekelashvili J, Krüger C, Bachmann O, Westendorf AM, Buer J, Liblau R, Manns MP, Korangy F, Greten TF.

Gastroenterology. 2008 Sep;135(3):871-81, 881.e1-5. doi: 10.1053/j.gastro.2008.06.032. Epub 2008 Jun 12.

PMID:
18674538
10.

Immune modulation by melanoma-derived factors.

Ilkovitch D, Lopez DM.

Exp Dermatol. 2008 Dec;17(12):977-85. doi: 10.1111/j.1600-0625.2008.00779.x. Epub 2008 Jul 17. Review.

PMID:
18643844
11.

B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.

Wahl C, Bochtler P, Chen L, Schirmbeck R, Reimann J.

Gastroenterology. 2008 Sep;135(3):980-8. doi: 10.1053/j.gastro.2008.05.076. Epub 2008 Jun 4.

PMID:
18621049
12.

Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta.

Wei S, Shreiner AB, Takeshita N, Chen L, Zou W, Chang AE.

Cancer Res. 2008 Jul 1;68(13):5432-8. doi: 10.1158/0008-5472.CAN-07-6598.

13.

Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion.

Dugast AS, Haudebourg T, Coulon F, Heslan M, Haspot F, Poirier N, Vuillefroy de Silly R, Usal C, Smit H, Martinet B, Thebault P, Renaudin K, Vanhove B.

J Immunol. 2008 Jun 15;180(12):7898-906.

14.

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Krüger C, Manns MP, Greten TF, Korangy F.

Gastroenterology. 2008 Jul;135(1):234-43. doi: 10.1053/j.gastro.2008.03.020. Epub 2008 Mar 21. Erratum in: Gastroenterology. 2011 Aug;141(2):779.

PMID:
18485901
15.

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ.

Cancer Immunol Immunother. 2009 Jan;58(1):49-59. doi: 10.1007/s00262-008-0523-4. Epub 2008 Apr 30.

16.

PD-1 and its ligands in tolerance and immunity.

Keir ME, Butte MJ, Freeman GJ, Sharpe AH.

Annu Rev Immunol. 2008;26:677-704. doi: 10.1146/annurev.immunol.26.021607.090331. Review.

PMID:
18173375
17.
18.
19.

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response.

Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S.

J Immunol. 2007 Jul 15;179(2):977-83.

20.

Thermal injury elevates the inflammatory monocyte subpopulation in multiple compartments.

Noel JG, Osterburg A, Wang Q, Guo X, Byrum D, Schwemberger S, Goetzman H, Caldwell CC, Ogle CK.

Shock. 2007 Dec;28(6):684-93.

PMID:
17607156

Supplemental Content

Support Center